Listando por materia "Antidepressius"
Mostrando ítems 1-6 de 6
-
3,4-Methylenedioxy methamphetamine, synthetic cathinones and psychedelics: From recreational to novel psychotherapeutic drugs
(Frontiers in Psychiatry, 2022)The utility of classical drugs used to treat psychiatric disorders (e.g., antidepressants, anxiolytics) is often limited by issues of lack of efficacy, delayed onset of action or side effects. Psychoactive ... -
Adherence to a Mediterranean diet and leisure-time physical activity are associated with reduced initiation of antidepressant, anxiolytic, antipsychotic and antiseizure drug use in older adults: a cohort study
(Age and ageing, 2025, 54(4): afaf088, 2025-04)Background We explored how adherence to the Mediterranean diet (MedDiet) and leisure-time physical activity (LTPA) impact psychoactive medication use in older adults. Methods We assessed the ... -
CES1 and SLC6A2 genetic variants as predictors of response to methylphenidate in autism spectrum disorders
(Pharmacogenomics and personalized medicine, 2022, vol. 15, p. 951-957, 2022-11)Purpose Autistic spectrum disorders (ASD) children and adolescents usually present comorbidities, with 40–70% of them affected by attention deficit hyperactivity disorders (ADHD). The first option of ... -
Pharmacogenetic influences on the response to pharmacological treatment in autism spectrum disorders
(Journal of Translational Genetics and Genomics, 2021, 5:278-287, 2021-07)Aim: About a third of patients with autism spectrum disorder (ASD) receive pharmacological treatment for comorbid symptoms. However, 30%-50% do not respond adequately and/or present severe and long-lasting ... -
Pharmacogenetic interventions improve the clinical outcome of treatment-resistant autistic spectrum disorder sufferers
(Pharmaceutics, 2022, 14 (5), 999, 2022-05)BACKGROUND: Autistic spectrum disorders (ASD) are severe neurodevelopmental alterations characterised by deficits in social communication and repetitive and restricted behaviours. About a third of ... -
Trajectories of antidepressant use and 6-year change in body weight: a prospective population-based cohort study
(Frontiers in Psychiatry, 2024, 15: 1464898, 2024-12)Background: Antidepressant drug treatment may be associated with weight gain, but long-term studies are lacking. Methods: We included 3,127 adults (1,701 women) from the REGICOR study, aged 55.6 (SD ...